What Is Phenibut?
Phenibut (β-phenyl-γ-aminobutyric acid) is a synthetic GABA analogue that acts mainly as a GABA-B receptor agonist 1Reference 1ReviewPhenibut: a drug with one too many “buts” — reviewView study →. Developed in the Soviet Union in the 1960s, it is used clinically in Russia and some neighbouring countries as an anxiolytic and sleep aid, but it is not an approved medicine or dietary supplement in most of the world, where it is sold grey-market as a “nootropic.” It is taken for anxiety, stress and sleep, and its calming, sometimes euphoric effects come with a genuine and well-documented liability for tolerance, dependence and withdrawal.
Evidence
Phenibut readily crosses the blood-brain barrier and produces its effects primarily through GABA-B receptor agonism, with additional activity reported at GABA-A and at α2δ subunits of voltage-gated calcium channels 1Reference 1ReviewPhenibut: a drug with one too many “buts” — reviewView study →. The bulk of the modern English-language literature is not efficacy trials but case reports and reviews of harm — intoxication, dependence and a withdrawal syndrome that can be severe (marked agitation, psychosis, autonomic instability) and has required hospitalisation and aggressive pharmacologic management, sometimes managed with baclofen or benzodiazepine/phenobarbital tapers 1,2Reference 1ReviewPhenibut: a drug with one too many “buts” — reviewView study →Reference 2Case reportAcute phenibut withdrawal: a comprehensive literature review and illustrative case report — review/case reportView study →. Original Soviet-era clinical use as an anxiolytic is frequently cited, but I did not find robust modern randomised controlled trial evidence for its anxiety or sleep benefit in this quick pass; treat efficacy claims as weakly evidenced relative to the clearly documented dependence risk.
Dosage & Safety
Reported doses cluster roughly in the 250–1000 mg per dose range, but this is drawn from case literature and user reports, not a validated therapeutic recommendation — and higher or repeated dosing is exactly where dependence and overdose reports arise. Phenibut carries a real, documented risk of physical dependence and a potentially dangerous withdrawal syndrome, including rebound anxiety, insomnia, agitation, hallucinations and, in severe cases, psychosis and autonomic instability 1,2Reference 1ReviewPhenibut: a drug with one too many “buts” — reviewView study →Reference 2Case reportAcute phenibut withdrawal: a comprehensive literature review and illustrative case report — review/case reportView study →. Tolerance can build quickly with daily use. It should not be combined with alcohol, benzodiazepines, opioids or other CNS depressants. It is a prescription/research-only or unscheduled grey-market substance depending on jurisdiction, not an approved dietary supplement in most countries. Pregnancy, interaction and long-term-safety data are not adequately characterised. This entry is informational only and is not medical advice.
References
- Gurley BJ, Koturbash I (2024). Phenibut: a drug with one too many “buts” — review. Basic & Clinical Pharmacology & Toxicology. https://pubmed.ncbi.nlm.nih.gov/39197876/
- Hardman MI, Sprung J, Weingarten TN (2019). Acute phenibut withdrawal: a comprehensive literature review and illustrative case report — review/case report. Bosnian Journal of Basic Medical Sciences. https://pubmed.ncbi.nlm.nih.gov/30501608/